ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,199Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 917

$533K Total Retail Price of All Prescriptions

Rank: 101 out of 917

368 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 368 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

14% of this provider’s 368 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 10,204 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
LISINOPRIL 895 704 1 1
LEVOTHYROXINE SODIUM 560 440 2 3
CARVEDILOL 538 413 3 33
OMEPRAZOLE 514 396 4 4
WARFARIN SODIUM 434 314 5 10
FUROSEMIDE 319 259 6 7
METOPROLOL SUCCINATE 316 276 7 18
SIMVASTATIN 311 263 8 2
PRAVASTATIN SODIUM 303 224 9 20
SOTALOL 280 253 10 240
ATENOLOL 274 181 11 12
CLOPIDOGREL 256 213 12 50
ATORVASTATIN CALCIUM 240 216 13 14
POTASSIUM CHLORIDE 205 168 14 16
CRESTOR 199 136 15 30
CITALOPRAM HBR 196 139 16 15
DIGOXIN 187 138 17 41
TRAZODONE HCL 186 121 18 22
ZOLPIDEM TARTRATE 181 120 19 21
HYDROCODONE-ACETAMINOPHEN 177 124 S3 20 6
LOSARTAN POTASSIUM 175 146 21 13
PLAVIX 155 131 22 84
AMLODIPINE BESYLATE 144 134 23 5
METOPROLOL TARTRATE 139 120 24 11
TORSEMIDE 137 118 25 187
GABAPENTIN 136 68 26 17
CIPROFLOXACIN HCL 123 91 27 72
AMIODARONE HCL 123 114 27 233
DIOVAN 112 107 29 49
METHYLPREDNISOLONE 94 72 30 201
LOVASTATIN 87 64 31 19
SPIRONOLACTONE 86 55 32 55
RANITIDINE HCL 85 67 33 29
CEFUROXIME 85 71 33 262
HYDROXYCHLOROQUINE SULFATE 79 67 35 228
METFORMIN HCL 76 50 36 8
ALLOPURINOL 75 53 37 31
SPIRONOLACTONE-HCTZ 75 41 37 295
TRAMADOL HCL 74 41 39 28
RAMIPRIL 74 73 39 128
DOXYCYCLINE HYCLATE 73 47 41 169
PREDNISONE 73 67 41 34
PANTOPRAZOLE SODIUM 72 63 43 44
HYDROCHLOROTHIAZIDE 71 58 44 9
CYCLOBENZAPRINE HCL 69 42 R 45 65
NIASPAN 68 29 46 157
CALCITRIOL 62 50 47 213
FLUCONAZOLE 62 50 47 253
KLOR-CON M20 61 43 49 121
ADVAIR DISKUS 58 42 50 47
LANTUS SOLOSTAR 55 39 51 63
FOSINOPRIL SODIUM 55 52 51 372
AZITHROMYCIN 51 43 53 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.